1.
Khasabova IA, Gable J, Johns M, Khasabov SG, Kalyuzhny AE, Golovko MY, Golovko SA, Kiven S, Gupta K, Seybold VS, Simone DA. Inhibition of DAGLĪ² as a therapeutic target for pain in sickle cell disease. haematol [Internet]. 2023Mar.1 [cited 2024Jun.13];108(3):859-6. Available from: https://haematologica.org/article/view/haematol.2021.280460